DELFI Diagnostics Receives New York State Department of Health Clinical Laboratory Permit, Completing Authorization to Serve Health Systems Across All 50 States

▤ Summary

DELFI Diagnostics announced that it received a New York State Department of Health Clinical Laboratory Permit for its FirstLook Lung test. The approval allows the company to offer the test in New York and completes availability across all 50 U.S. states. The company says the permit strengthens its regulatory position and supports its longer-term path toward FDA approval for its blood-based cancer screening device. DELFI also highlights its CLIA, CAP, ISO 13485, and ISO 27001 certifications as part of its quality and data-security framework.

▦ Linked Companies